News | October 25, 2023
Sumitomo Pharma announces authorization in Canada of Orgovyx for treatment prostate cancer
Orgovyx is the first and only oral GnRH receptor antagonist approved for advanced prostate cancer in Canada
Orgovyx is the first and only oral GnRH receptor antagonist approved for advanced prostate cancer in Canada
The vaccine further advances Pfizer’s vaccine portfolio and builds on more than 20 years of expertise and knowledge in the prevention of meningococcal disease
Lupin enters into BTA with Lupin Manufacturing Solutions
Lokavant provides clinical trial intelligence
The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets
The companies will work with investigators to share the results with the scientific community
Norepinephrine Bitartrate Injection is used for restoration of blood pressure in adult patients
Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)
Strides Pharma Science Limited to acquire 100% in Strides Pharma Services Pvt Ltd.
Sarah currently serves as the Chief Financial Officer and Principal Accounting Officer for Criteo S.A.
Subscribe To Our Newsletter & Stay Updated
